Table 1. Characteristics of the two independent cohorts.
| |
|
Cohort A (n = 66) |
Cohort B (n = 67) |
||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Age (years) |
Median (range) |
59.9 |
(36.5–84.1) |
56.9 |
(34.7–79.9) |
| Menopause |
no |
35 |
53.03 |
19 |
28.78 |
| |
yes |
31 |
46.96 |
47 |
71.21 |
| Adjuvant chemotherapy |
no |
25 |
37.87 |
23 |
34.33 |
| |
yes |
41 |
62.12 |
44 |
65.67 |
| Adjuvant hormonotherapy |
no |
37 |
56.06 |
35 |
52.24 |
| |
yes |
29 |
43.93 |
32 |
47.76 |
| Adjuvant Avastin |
no |
- |
- |
36 |
58.06 |
| |
yes |
- |
- |
26 |
41.94 |
| PS |
0/1 |
51 |
72.27 |
42 |
62.68 |
| |
> 1 |
15 |
22.72 |
25 |
37.32 |
| ER |
No |
15 |
23.07 |
21 |
31.34 |
| |
yes |
50 |
76.92 |
46 |
68.66 |
| PgR |
no |
20 |
30.30 |
33 |
49.25 |
| |
yes |
44 |
66.66 |
34 |
50.75 |
| Her2/neu |
no |
46 |
79.31 |
52 |
81.25 |
| |
yes |
12 |
20.68 |
12 |
18.75 |
| Triple Negative (TNBT) |
no |
60 |
92.30 |
52 |
77.61 |
| yes | 5 | 7.69 | 15 | 22.39 | |